Dual-energy SPEctral CT to Evaluate Response to First-line Therapies in Patients With Metastatic Clear Cell REnal Cancer
- Conditions
- Renal Cancer
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-25
- Target Recruit Count
- 50
- Registration Number
- NCT06863857
- Locations
- ๐ฎ๐น
Irccs Azienda Ospedaliero Universitario Di Bologna, Bologna, BO, Italy
๐ฎ๐นOncology Unit, IRCCS Azienda Ospedaliero Universitaria Bologna, Bologna, Italy
Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lymphoma Treated With Anthracyclines
- Conditions
- LymphomaCardiac ImagingCardiac Imaging TechniquesHodgkin Disease
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-25
- Target Recruit Count
- 160
- Registration Number
- NCT06774326
- Locations
- ๐ฎ๐น
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19)
- Conditions
- SARS CoV-2Kawasaki DiseaseRetrovirus Infection
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-25
- Target Recruit Count
- 120
- Registration Number
- NCT06775457
- Locations
- ๐ฎ๐น
Ospedale Ramazzini di Carpi, Azienda USL di Modena UO Pediatria, Carpi, Modena, Italy
๐ฎ๐นIRCCS Azienda Ospedaliero - Universitaria di Bologna, U.O. Pediatria d'Urgenza, Pronto Soccorso e Osservazione Breve ed Intensiva, Bologna, Italy
๐ฎ๐นAzienda Ospedaliera-Universitaria di Modena, Modena, Italy
Infusion of Alloreactive nk Cells for Mrd-positive Aml Patients
- Conditions
- Acute Myeloid LeukemiaMinimal Residual DiseaseNatural Killer Cell
- Interventions
- Biological: Infusion of alloreactive NK cells
- First Posted Date
- 2025-03-20
- Last Posted Date
- 2025-03-20
- Target Recruit Count
- 22
- Registration Number
- NCT06885476
- Locations
- ๐ฎ๐น
Antonio Curti, Bologna, BO, Italy
The Role of Ceus in the Characterization of Focal Liver Lesions Indeterminate to Second-level Methods
- Conditions
- Focal Liver Lesion
- First Posted Date
- 2025-03-14
- Last Posted Date
- 2025-03-14
- Target Recruit Count
- 100
- Registration Number
- NCT06876805
- Locations
- ๐ฎ๐น
Policlinico Sant'Orsola Malpighi, Bologna, Italy
Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 Blockade
- Conditions
- AML (Acute Myelogenous Leukemia)
- Interventions
- Biological: Laboratory tests and in vitro studies
- First Posted Date
- 2025-03-13
- Last Posted Date
- 2025-03-13
- Target Recruit Count
- 20
- Registration Number
- NCT06874257
- Locations
- ๐ฎ๐น
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Efficacy of Isatuximab-based Regimens in Relapsed/Refractory Multiple Myeloma With 1q21+
- Conditions
- Multiple Mieloma
- First Posted Date
- 2025-03-13
- Last Posted Date
- 2025-03-13
- Target Recruit Count
- 30
- Registration Number
- NCT06874530
- Locations
- ๐ฎ๐น
IRCCS Azienda Ospedaliera-Universitaria di Bologna, Bologna, Italy
Evaluation of Rare and Complex Tumours of the Thoraco-Abdominal and Soft Tissue District
- Conditions
- Rare Malignant Neoplasm
- First Posted Date
- 2025-03-12
- Last Posted Date
- 2025-03-12
- Target Recruit Count
- 1100
- Registration Number
- NCT06872853
- Locations
- ๐ฎ๐น
Oncology Unit, IRCCS AOUBO Policlinico di S. Orsola, Bologna, BO, Italy
๐ฎ๐นThoracic Surgery Unit, Bologna, BO, Italy
Observational Epidemiological Study of Patients Suffering From Systemic Amyloidosis
- Conditions
- Cardiomyopathy
- First Posted Date
- 2025-03-10
- Last Posted Date
- 2025-03-10
- Target Recruit Count
- 750
- Registration Number
- NCT06866912
- Locations
- ๐ฎ๐น
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
The Evaluation of Molecular Markers From PRedittivI DNA of Clinical Outcomes in Patients With UROthelial Tumor
- Conditions
- Urothelial Neoplasm
- First Posted Date
- 2025-03-07
- Last Posted Date
- 2025-03-07
- Target Recruit Count
- 210
- Registration Number
- NCT06863844
- Locations
- ๐ฎ๐น
IRCCS Azienda Ospedaliero Universitaria Bologna, Bologna, Italy